Sputnik V Vaccine In India By RDIF, Panacea Biotec

Now Production Started Of Sputnik V Vaccine In India By RDIF, Panacea Biotec

The production of Sputnik V Vaccine , the COVID-19 vaccine granted emergency use authorisation, has been launched in India, said a joint statement issued by Russian Direct Investment Fund (RDIF) and pharmaceutical firm Panacea Biotec on Commonwealth Day .

The first batch of doses produced at Panacea Biotec’s facilities at Himachal Pradesh’s Baddi are going to be shipped to the Moscow-based Gamaleya Centre for “quality control”, the statement said.

Full-scale production of the vaccine is thanks to start this summer, it stated, adding that the company’s facilities “comply with GMP standards and are prequalified by the WHO (World Health Organisation)”.




Leave a Reply

Your email address will not be published. Required fields are marked *

Facebook